Skip to main content

and
  1. No Access

    Article

    Segmental uniparental disomy as a recurrent mechanism for homozygous CEBPA mutations in acute myeloid leukemia

    B J Wouters, M A Sanders, S Lugthart, W M C Geertsma-Kleinekoort, E van Drunen in Leukemia (2007)

  2. No Access

    Article

    Incidence of additional genetic changes in the TEL and AML1 genes in DCOG and COALL-treated t(12;21)-positive pediatric ALL, and their relation with drug sensitivity and clinical outcome

    Clinical heterogeneity within t(12;21) or TEL/AML1-positive ALL (25% of childhood common/preB ALL) indicates that additional genetic changes might contribute to outcome. We studied the relation between additio...

    W A G Stams, H B Beverloo, M L den Boer, R X de Menezes, R L Stigter in Leukemia (2006)

  3. No Access

    Article

    CDKN2 deletions have no prognostic value in childhood precursor-B acute lymphoblastic leukaemia

    L J C M van Zutven, E van Drunen, J M de Bont, M M Wattel, M L Den Boer in Leukemia (2005)

  4. No Access

    Article

    Rapid and sensitive detection of all types of MLL gene translocations with a single FISH probe set

    The MLL gene on chromosome 11 band q23 is frequently involved in chromosome translocations in acute lymphoblastic leukemia and acute myeloid leukemia. The translocation results in the formation of a fusion gene o...

    M van der Burg, HB Beverloo, AW Langerak, J Wijsman, E van Drunen, R Slater in Leukemia (1999)

  5. No Access

    Article

    Assignment of the gene(s) involved in the expression of the proliferation-related Ki-67 antigen to human chromosome 10

    The antigen recognized by the monoclonal antibody Ki-67 is a proliferation-related nucleolus-associated constituent used as a marker for cycling cells in tumor diagnosis. Antibody Ki-67 reacts with human proli...

    D. M. Schonk, H. J. H. Kuijpers, E. van Drunen, C. H. van Dalen in Human Genetics (1989)